$ILXP
ECOMINAS CORP.
CIK:0001115864|SEC Filings
CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) | ||||
| Sales | $ 0 | $ 0 | $ 0 | $ 0 |
| Operating expenses | ||||
| Professional fees | 15,820 | 3,367 | 45,371 | 13,367 |
| General and administrative | 700 | 0 | 1,984 | 594 |
| Total operating expenses | 16,520 | 3,367 | 47,355 | 13,961 |
| Loss from operations | (16,520) | (3,367) | (47,355) | (13,961) |
| Other expenses | ||||
| Interest expense | (4,082) | (2,411) | (6,935) | (4,795) |
| Total other expenses | (4,082) | (2,411) | (6,935) | (4,795) |
| Net loss before tax provision | (20,602) | (5,778) | (54,290) | (18,756) |
| Tax provision | 0 | 0 | 0 | 0 |
| Net loss | $ (20,602) | $ (5,778) | $ (54,290) | $ (18,756) |
| Net loss per common share: basic and diluted | $ (0.10) | $ (0.03) | $ (0.25) | $ (0.09) |
| Weighted average common shares outstanding -basic and diluted | 215,342 | 215,342 | 215,342 | 215,342 |
CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) |
6 Months Ended | |
|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Cash Flows from Operating Activities | ||
| Net loss | $ (54,290) | $ (18,756) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Stock-based compensation | 0 | 0 |
| Changes in assets and liabilities | ||
| Accounts payable and accrued expenses | 6,751 | 3,662 |
| Net cash used in operating activities | (47,539) | (15,094) |
| Cash Flows from Financing Activities | ||
| Proceeds from notes payable | 48,305 | 15,094 |
| Net cash provided by financing activities | 48,305 | 15,094 |
| Net increase in cash | 766 | 0 |
| Cash, beginning of period | 0 | 0 |
| Cash, end of period | 766 | 0 |
| Supplemental disclosure of cash flow information | ||
| Cash paid for interest | 0 | 0 |
| Cash paid for taxes | $ 0 | $ 0 |
CONDENSED BALANCE SHEETS - USD ($) |
Jun. 30, 2026 |
Dec. 31, 2025 |
|---|---|---|
| ASSETS | ||
| Cash | $ 766 | $ 0 |
| Total current assets | 766 | 0 |
| Total assets | 766 | 0 |
| Current liabilities | ||
| Accounts payable and accrued expenses | 246,329 | 239,578 |
| Notes payable | 163,710 | 115,405 |
| Notes payable - related party | 68,785 | 68,785 |
| Due to related parties | 5,293 | 5,293 |
| Total current liabilities | 484,117 | 429,061 |
| Total liabilities | 484,117 | 429,061 |
| Commitments and Contingencies (Note 6) | 0 | 0 |
| Common Shares 700,000,000 authorized shares, par value $0.0001 215,342 and 215,342 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 22 | 22 |
| Additional paid-in capital | 5,025,609 | 5,025,609 |
| Accumulated deficit | (5,509,482) | (5,455,192) |
| Total stockholders' deficit | (483,351) | (429,061) |
| Total liabilities and stockholders' deficit | 766 | 0 |
| Series B Preferred Stock [Member] | ||
| Current liabilities | ||
| Preferred stock value | 500 | 500 |
| Series A Preferred Stock [Member] | ||
| Current liabilities | ||
| Preferred stock value | $ 0 | $ 0 |